Your source for industry focused blog articles, news, videos and interactive polls and quizzes.

Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
Biotech News | Clinical Trial News | Life Science News | News | Pharma News

GSK-licensed Ris-Rez met the overall survival endpoint in a Phase III small-cell lung cancer trial, marking a first for B7-H3-targeted ADCs.

How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
Blogs

Pharma and Biotech M&As 2026 Deal Watcher
Pharma and Biotech M&As 2026
Blogs

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
Trutakna (atacicept) is given as a once-weekly under-the-skin injection, and patients can self-administer it at home using an autoinjector. Photo courtesy of Vera Therapeutics.
News
News Life Science News Pharma News Biotech News Medical Device News Healthcare News Videos Blogs Life Sciences Quizzes & Polls

Vitals Highlights

How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
Blogs

Pharma and Biotech M&As 2026 Deal Watcher
Pharma and Biotech M&As 2026
Blogs

How Do Online Health Communities Play a Role in Shaping the Patient Experience?
Patients use online patient communities to discuss treatment experiences, side effects, adherence challenges and access barriers.
Sponsored

World Hepatitis Day 2026: What to Know About Hepatitis and New Treatment Updates
Hepatitis B can pass from mother to child at birth, making early screening and prevention essential.
Blogs

What’s the Most Important Skill for Life Sciences Professionals Over the Next 5 Years?
Life Sciences Professionals
Life Sciences Quizzes & Polls

Why Rare Disease Trial Design Requires the “Right Patients at the Right Time”
Rare Disease Trial Design
Blogs

Reducing Life Sciences Supply Chain Delays With Visibility and AI
Life sciences supply chain delays often start long before products are shipped, driven by forecasting gaps, quality issues, partner constraints and slow handoffs.
Blogs

Pharma and Biotech IPOs of 2026: A Running List
Blogs

Actuate Therapeutics and the Rise of Regional Oncology Biotech Hubs
Blogs

Fibroids Awareness Month 2026: Understanding Symptoms and Treatment Choices
Uterine fibroids are common growths that can affect bleeding, pain, pregnancy and quality of life, especially for women in their 30s, 40s and 50s.
Blogs

Why Latvia Is Building Momentum in Biomedicine, Digital Health and Precision Medicine
Why Latvia Is Building Momentum in Biomedicine, Digital Health and Precision Medicine
Blogs

CERo Therapeutics on Why Talent Still Comes First for Biotech Growth
Blogs

Sarcoma Awareness Month 2026: New Trial Updates Show a More Targeted Treatment Era
Sarcoma includes many rare bone and soft tissue cancer subtypes, making diagnosis and treatment complex.
Blogs

Deck Bio on Solid Tumor Immunotherapy, Talent and Biotech Infrastructure
Blogs

Cell Therapy for Degenerative Disc Disease: Clinical Trial Priorities and Regulatory Rigor
degenerative disc disease
Blogs

Bone Screws Don’t Have to Stay Forever: Bioretec on Absorbable Metal Fixation
Absorbable Metal Implants
Blogs

News

More
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
News | Biotech News | Clinical Trial News | Life Science News | Pharma News

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
News

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants
News

FDA Expands Casgevy Approval for Children as Young as 2 With Sickle Cell Disease
The expanded approval could give families an earlier treatment option before years of pain crises, transfusions and disease-related organ damage accumulate.
News

Parabilis Medicines IPO Supports Cancer Drug Pipeline Targeting “Undruggable” Proteins
Parabilis is using its Helicon platform to target intracellular cancer drivers that have been difficult for many existing drug types to reach.
News

FDA Clears Dexcom’s Stelo as First OTC CGM for Children
Stelo pairs a wearable sensor with a smartphone app that displays glucose measurements and trends every 15 minutes. Photo courtesy of Dexcom.
News

Life Science News

More
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
News | Biotech News | Clinical Trial News | Life Science News | Pharma News

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
News

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants
News

FDA Expands Casgevy Approval for Children as Young as 2 With Sickle Cell Disease
The expanded approval could give families an earlier treatment option before years of pain crises, transfusions and disease-related organ damage accumulate.
News

Parabilis Medicines IPO Supports Cancer Drug Pipeline Targeting “Undruggable” Proteins
Parabilis is using its Helicon platform to target intracellular cancer drivers that have been difficult for many existing drug types to reach.
News

FDA Clears Dexcom’s Stelo as First OTC CGM for Children
Stelo pairs a wearable sensor with a smartphone app that displays glucose measurements and trends every 15 minutes. Photo courtesy of Dexcom.
News

Pharma News

More
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
News | Biotech News | Clinical Trial News | Life Science News | Pharma News

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
News

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants
News

FDA Expands Casgevy Approval for Children as Young as 2 With Sickle Cell Disease
The expanded approval could give families an earlier treatment option before years of pain crises, transfusions and disease-related organ damage accumulate.
News

Parabilis Medicines IPO Supports Cancer Drug Pipeline Targeting “Undruggable” Proteins
Parabilis is using its Helicon platform to target intracellular cancer drivers that have been difficult for many existing drug types to reach.
News

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery
Cypsedo (cipepofol) injection is to be used for the induction of general anesthesia in adults undergoing surgery.
News

Biotech News

More
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
News | Biotech News | Clinical Trial News | Life Science News | Pharma News

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
News

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants
News

FDA Expands Casgevy Approval for Children as Young as 2 With Sickle Cell Disease
The expanded approval could give families an earlier treatment option before years of pain crises, transfusions and disease-related organ damage accumulate.
News

Parabilis Medicines IPO Supports Cancer Drug Pipeline Targeting “Undruggable” Proteins
Parabilis is using its Helicon platform to target intracellular cancer drivers that have been difficult for many existing drug types to reach.
News

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs
News

Medical Device News

More
Stelo pairs a wearable sensor with a smartphone app that displays glucose measurements and trends every 15 minutes. Photo courtesy of Dexcom.

FDA Clears Dexcom’s Stelo as First OTC CGM for Children
News | Approvals News | Digital Health News | Life Science News | Medical Device News

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment
News

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options
News

Mobia Medical IPO Raises $150M for Stroke Recovery Device
News

MiniMed IPO Points to Smarter Diabetes Devices
News

FDA Clears Custom Titanium Cranial Implant for Skull Repair
News

Alamar Biosciences IPO Raises $219.9M for Blood-Based Biomarker Tools
News

Healthcare News

More
Cypsedo (cipepofol) injection is to be used for the induction of general anesthesia in adults undergoing surgery.

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery
News | Approvals News | Healthcare News | Life Science News | Pharma News

Healthcare IPOs in 2026: A Roundup
News

GMR Solutions IPO Brings Ambulance Services to the NYSE
News

Hantavirus Cruise Ship Outbreak Leaves 3 Dead, WHO Investigates Source
News

New Report Finds 75% of Women Skip Healthcare Due to Scheduling Constraints
News

500,000 UK Biobank Records Leaked and Listed for Sale on Alibaba
News

Only 9% of Americans Know How to Maintain Brain Health, Alzheimer’s Association Finds
News

Based on your interests

Edit Profile

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.
News

How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
How the Stem Cell Network Is Accelerating Regenerative Medicine from Lab to Clinic in Canada
Blogs

Pharma and Biotech M&As 2026 Deal Watcher
Pharma and Biotech M&As 2026
Blogs